SCHEMBL6738547

SCHEMBL6738547

CCC(C)OCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14468106 1.00
SCHEMBL2754603 0.90 LMNA (0.38)
SCHEMBL16807876 0.86 TDP1 (0.35)
SCHEMBL4899893 0.84 LMNA (0.37)
SCHEMBL17385134 0.78
SCHEMBL12549712 0.74
SCHEMBL3401323 0.74
SCHEMBL15697271 0.74
SCHEMBL1972931 0.74
SCHEMBL1972865 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230129965-A1 HYDROPHILIC AND OLEOPHOBIC POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
WO-2021225823-A1 SYNTHESIS OF VINYLIC PROTECTED ALCOHOL INTERMEDIATES AMGEN INC. (US) 2021-11-11 WO disclosed
US-20180030175-A1 POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-01 US disclosed
US-20170211089-A1 NOVEL SUGAR TRANSPORTERS CARNEGIE INSTITUTION OF WASHINGTON 2017-07-27 US disclosed
US-20150353991-A1 MIRNA TARGETS CHILDREN'S MEDICAL CENTER CORPORATION 2015-12-10 US disclosed
WO-2014179765-A2 NOVEL HUMAN MIRNAS FOR USE IN DIAGNOSIS, PROGNOSIS AND THERAPY OF HUMAN CONDITIONS AND DISEASES THOMAS JEFFERSON UNIVERSITY (US) 2014-11-06 WO disclosed
WO-2014150226-A1 GENETIC LOCI ASSOCIATED WITH FROGEYE LEAF SPOT RESISTANCE AND BROWN STEM ROT RESISTANCE AND METHODS OF USE PIONEER HI-BRED INTERNATIONAL, INC. (US) 2014-09-25 WO disclosed
US-20130184462-A1 METHOD FOR PREDICTING AND MODELING ANTI-PSYCHOTIC ACTIVITY USING VIRTUAL SCREENING MODEL COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-07-18 US disclosed
US-8183262-B2 Central nervous system disorders; metabotropic glutamate receptors (mGluR); 2-(4-Pyridin-3-yl-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyrimidine HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
US-20110052536-A1 METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION AND COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-03-03 US disclosed
EP-2284279-A1 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders Epigenomics AG (DE) 2011-02-16 EP disclosed
US-20090318474-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR 2 ANTAGONISTS GATTI MCARTHUR SILVIA 2009-12-24 US disclosed